Uncategorized
Non-operative appendicitis treatment
Article: ANZ J Surg. 2024 Sep;94(9):1569-1577. “Non-operative management of uncomplicated appendicitis in children: a randomized, controlled, non-inferiority study evaluating safety and efficacy”…
Intranasal treatments for sleep disorders
Article: JAMA Pediatr. 2026 Mar 1;180(3):240-249. “Intranasal Treatments for Children With Sleep-Disordered Breathing: The MIST+ Randomized Clinical Trial” Reviewer:Dr.Tahir…
Probiotics for infant functional GI disorders
Article: Eur J Pediatr. 2024 May;183(5):2311-2324. “Effect of Lactobacillus reuteri NCIMB 30351 drops on symptoms of infantile functional gastrointestinal disorders and gut…
Emollient for prevention of eczema
Article: Lancet. 2020 Mar 21;395(10228):962-972. “Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial“ Reviewer: Dr. Tyler Emery …
Propranolol vs Atenolol in Infants with Hemangioma
Article: JAMA otolaryngology– head & neck surgery. 2021 Jul 1;147(7):599-607. “Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile…
Midline vs. Peripheral IV Catheters in Longer Term Pediatric Patients
Article: JAMA Pediatrics. 2023 Nov 1;177(11):1132-1140. “Midline Compared With Peripheral Intravenous Catheters for Therapy of 4 Days or Longer in Pediatric Patients….
Dupilumab for Eosinophilic Esophagitis
Article: Lancet Gastroenterol Hepatol. 2023 Nov;8(11):990-1004. Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis…
Brentuximab Vedotin for Hodgkin’s Lymphoma
Article: N Engl J Med. 2022 Nov 3;387(18):1649-1660. Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma Reviewer: Dr. Asba Memon…
Omalizumab for food allergies
Article: N Engl J Med. 2024 Mar 7;390(10):889-899 Omalizumab for the Treatment of Multiple Food Allergies Reviewer: Dr. Myranda Grismore …
Voxelotor for sickle cell disease
Article: Lancet Haematol. 2021 May;8(5):e306-e307. PMID: 33838114 Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an…